Citigroup’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed -$10 5725
2026
Q1
$10 Buy
+1
New +$7 ﹤0.01% 5736
2025
Q4
Sell
-1
Closed -$4 6060
2025
Q3
$4 Buy
+1
New +$4 ﹤0.01% 5990
2024
Q4
Sell
-8
Closed -$33 5829
2024
Q3
$33 Hold
8
﹤0.01% 5580
2024
Q2
$199 Hold
8
﹤0.01% 5432
2024
Q1
$206 Hold
8
﹤0.01% 5479
2023
Q4
$182 Hold
8
﹤0.01% 5538
2023
Q3
$152 Hold
8
﹤0.01% 5351
2023
Q2
$221 Buy
8
+2
+33% +$57 ﹤0.01% 5422
2023
Q1
$140 Sell
6
-146
-96% -$4.7K ﹤0.01% 5270
2022
Q4
$4.81K Buy
152
+55
+57% +$1.73K ﹤0.01% 5039
2022
Q3
$3K Sell
97
-933
-91% -$32.2K ﹤0.01% 5355
2022
Q2
$31K Buy
1,030
+491
+91% +$45K ﹤0.01% 4768
2022
Q1
$73K Sell
539
-502
-48% -$52.9K ﹤0.01% 4565
2021
Q4
$136K Sell
1,041
-23,165
-96% -$2.93M ﹤0.01% 4566
2021
Q3
$2.27M Buy
24,206
+17,630
+268% +$1.79M ﹤0.01% 2440
2021
Q2
$673K Buy
6,576
+6,473
+6,284% +$1.13M ﹤0.01% 3497
2021
Q1
$19K Sell
103
-137
-57% -$30.2K ﹤0.01% 5276
2020
Q4
$82K Buy
+240
New +$56.6K ﹤0.01% 5695

Other funds holding LONA

Citigroup's LONA Position: Q2 2026 in Review

Citigroup sold out of LeonaBio Inc (LONA) in Q2 2026, closing a stake of 1 share — an estimated $10 sold.

Citigroup first reported a position in LONA in Q4 2020 and held it in 18 quarters. The position peaked at $2.27M in Q3 2021. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • Citigroup reported no remaining LeonaBio Inc position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 1 LeonaBio Inc share in Q2 2026, an estimated $10.
  • Citigroup first reported a position in LeonaBio Inc in Q4 2020 and held it in 18 quarters.
  • Citigroup's LeonaBio Inc position peaked at $2.27M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.